AB SCIENCE SA (AB.PA) Stock Overview
Europe - EPA:AB - FR0010557264 - Common Stock
AB.PA Key Statistics, Chart & Performance
The current stock price of AB.PA is 1.48 EUR. In the past month the price increased by 18.37%. In the past year, price increased by 50.1%.
AB.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY.DE | ELI LILLY & CO | 51.08 | 671.99B | ||
| 1LLY.MI | ELI LILLY & CO | 51.01 | 671.13B | ||
| ZEG.DE | ASTRAZENECA PLC | 19.16 | 451.43B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 19.14 | 396.36B | ||
| JNJ.DE | JOHNSON & JOHNSON | 19.07 | 395.06B | ||
| RHO.DE | ROCHE HOLDING AG-BR | 15.07 | 257.83B | ||
| 1ROG.MI | ROCHE HOLDING AG-GENUSSCHEIN | 14.29 | 244.39B | ||
| 1NOVN.MI | NOVARTIS AG-REG | 14.89 | 216.82B | ||
| NOT.DE | NOVARTIS AG-REG | 14.86 | 216.31B | ||
| NOV.DE | NOVO NORDISK A/S-B | 14.55 | 215.95B | ||
| SAN.PA | SANOFI | 11.28 | 207.58B | ||
| SNW.DE | SANOFI | 11.17 | 205.61B |
Related stock screener links
About AB.PA
Company Profile
AB Science SA operates as a pharmaceutical company, which engages in the research, development, and marketing of synthetic therapeutic molecules for pathologies with high medical need, in diseases of the central nervous system, cancers, and inflammatory diseases. The company is headquartered in Paris, Ile-De-France and currently employs 39 full-time employees. The company went IPO on 2010-04-21. The company is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine. The main focus of the Company is the development of tyrosine kinase inhibitors, for instance Masitinib which is a tyrosine kinase inhibitor used as a veterinary medicine in the treatment of canine mast cell tumors. The firm is present in the United States and Europe. As of December 31, 2013, the Company operated though a subsidiary, AB Science USA LCC, based in the United States.
Company Info
AB SCIENCE SA
3, avenue George V
Paris ILE-DE-FRANCE FR
Employees: 39
Phone: 33147200014
AB SCIENCE SA / AB.PA FAQ
What is the stock price of AB SCIENCE SA today?
The current stock price of AB.PA is 1.48 EUR. The price increased by 1.65% in the last trading session.
What is the ticker symbol for AB SCIENCE SA stock?
The exchange symbol of AB SCIENCE SA is AB and it is listed on the Euronext Paris - Matif exchange.
On which exchange is AB.PA stock listed?
AB.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for AB SCIENCE SA stock?
10 analysts have analysed AB.PA and the average price target is 3.53 EUR. This implies a price increase of 138.46% is expected in the next year compared to the current price of 1.48. Check the AB SCIENCE SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AB SCIENCE SA worth?
AB SCIENCE SA (AB.PA) has a market capitalization of 94.29M EUR. This makes AB.PA a Micro Cap stock.
How many employees does AB SCIENCE SA have?
AB SCIENCE SA (AB.PA) currently has 39 employees.
What are the support and resistance levels for AB SCIENCE SA (AB.PA) stock?
AB SCIENCE SA (AB.PA) has a support level at 1.32 and a resistance level at 1.5. Check the full technical report for a detailed analysis of AB.PA support and resistance levels.
Is AB SCIENCE SA (AB.PA) expected to grow?
The Revenue of AB SCIENCE SA (AB.PA) is expected to grow by 0.88% in the next year. Check the estimates tab for more information on the AB.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AB SCIENCE SA (AB.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AB.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AB.PA, evaluating the profitability, health, valuation and growth aspects
- AB SCIENCE SA (AB.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AB SCIENCE SA (AB.PA) Sales and EPS estimates to see what analysts future expectations are.
- AB SCIENCE SA (AB.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AB SCIENCE SA (AB.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- AB SCIENCE SA (AB.PA) Stock Chart to make your own analysis
- AB SCIENCE SA (AB.PA) Latest news and press-releases to stay up to date.
Does AB SCIENCE SA (AB.PA) stock pay dividends?
AB.PA does not pay a dividend.
What is the Price/Earnings (PE) ratio of AB SCIENCE SA (AB.PA)?
AB SCIENCE SA (AB.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.15).
AB.PA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to AB.PA. When comparing the yearly performance of all stocks, AB.PA is one of the better performing stocks in the market, outperforming 91.12% of all stocks.
AB.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AB.PA. AB.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
AB.PA Financial Highlights
Over the last trailing twelve months AB.PA reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 40.46% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.79% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AB.PA Forecast & Estimates
10 analysts have analysed AB.PA and the average price target is 3.53 EUR. This implies a price increase of 138.46% is expected in the next year compared to the current price of 1.48.
For the next year, analysts expect an EPS growth of 7.32% and a revenue growth 0.88% for AB.PA